77 related articles for article (PubMed ID: 12738599)
1. Activated protein C inhibits the expression of platelet-derived growth factor in the lung.
Shimizu S; Gabazza EC; Taguchi O; Yasui H; Taguchi Y; Hayashi T; Ido M; Shimizu T; Nakagaki T; Kobayashi H; Fukudome K; Tsuneyoshi N; D'Alessandro-Gabazza CN; Izumizaki M; Iwase M; Homma I; Adachi Y; Suzuki K
Am J Respir Crit Care Med; 2003 May; 167(10):1416-26. PubMed ID: 12738599
[TBL] [Abstract][Full Text] [Related]
2. Hepatoma-derived growth factor is involved in lung remodeling by stimulating epithelial growth.
Mori M; Morishita H; Nakamura H; Matsuoka H; Yoshida K; Kishima Y; Zhou Z; Kida H; Funakoshi T; Goya S; Yoshida M; Kumagai T; Tachibana I; Yamamoto Y; Kawase I; Hayashi S
Am J Respir Cell Mol Biol; 2004 Apr; 30(4):459-69. PubMed ID: 12972397
[TBL] [Abstract][Full Text] [Related]
3. Lung pathology in platelet-derived growth factor transgenic mice: effects of genetic background and fibrogenic agents.
Li J; Ortiz LA; Hoyle GW
Exp Lung Res; 2002 Sep; 28(6):507-22. PubMed ID: 12217216
[TBL] [Abstract][Full Text] [Related]
4. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases.
Okuma T; Terasaki Y; Kaikita K; Kobayashi H; Kuziel WA; Kawasuji M; Takeya M
J Pathol; 2004 Dec; 204(5):594-604. PubMed ID: 15538737
[TBL] [Abstract][Full Text] [Related]
5. Role of osteopontin in the pathogenesis of bleomycin-induced pulmonary fibrosis.
Takahashi F; Takahashi K; Okazaki T; Maeda K; Ienaga H; Maeda M; Kon S; Uede T; Fukuchi Y
Am J Respir Cell Mol Biol; 2001 Mar; 24(3):264-71. PubMed ID: 11245625
[TBL] [Abstract][Full Text] [Related]
6. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
7. Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis.
Miyazaki Y; Araki K; Vesin C; Garcia I; Kapanci Y; Whitsett JA; Piguet PF; Vassalli P
J Clin Invest; 1995 Jul; 96(1):250-9. PubMed ID: 7542280
[TBL] [Abstract][Full Text] [Related]
8. Platelet-derived growth factor-producing CD4+ Foxp3+ regulatory T lymphocytes promote lung fibrosis.
Lo Re S; Lecocq M; Uwambayinema F; Yakoub Y; Delos M; Demoulin JB; Lucas S; Sparwasser T; Renauld JC; Lison D; Huaux F
Am J Respir Crit Care Med; 2011 Dec; 184(11):1270-81. PubMed ID: 21868503
[TBL] [Abstract][Full Text] [Related]
9. Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity.
Pini A; Shemesh R; Samuel CS; Bathgate RA; Zauberman A; Hermesh C; Wool A; Bani D; Rotman G
J Pharmacol Exp Ther; 2010 Dec; 335(3):589-99. PubMed ID: 20826567
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin.
Cabrera S; Gaxiola M; Arreola JL; Ramírez R; Jara P; D'Armiento J; Richards T; Selman M; Pardo A
Int J Biochem Cell Biol; 2007; 39(12):2324-38. PubMed ID: 17702637
[TBL] [Abstract][Full Text] [Related]
11. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.
Kim JW; Rhee CK; Kim TJ; Kim YH; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim KH; Kim YK
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1055-63. PubMed ID: 20659133
[TBL] [Abstract][Full Text] [Related]
12. Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice.
Aono Y; Nishioka Y; Inayama M; Ugai M; Kishi J; Uehara H; Izumi K; Sone S
Am J Respir Crit Care Med; 2005 Jun; 171(11):1279-85. PubMed ID: 15735062
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of lipoxin A4 receptor by thromboxane A2 signaling in RAW246.7 cells in vitro and bleomycin-induced lung fibrosis in vivo.
Sato Y; Kitasato H; Murakami Y; Hashimoto A; Endo H; Kondo H; Inoue M; Hayashi I
Biomed Pharmacother; 2004; 58(6-7):381-7. PubMed ID: 15271420
[TBL] [Abstract][Full Text] [Related]
14. Loss of RAGE in pulmonary fibrosis: molecular relations to functional changes in pulmonary cell types.
Queisser MA; Kouri FM; Königshoff M; Wygrecka M; Schubert U; Eickelberg O; Preissner KT
Am J Respir Cell Mol Biol; 2008 Sep; 39(3):337-45. PubMed ID: 18421017
[TBL] [Abstract][Full Text] [Related]
15. Presence of platelet-derived growth factor in normal and fibrotic lung is specifically associated with interstitial macrophages, while both interstitial macrophages and alveolar epithelial cells express the c-sis proto-oncogene.
Vignaud JM; Allam M; Martinet N; Pech M; Plenat F; Martinet Y
Am J Respir Cell Mol Biol; 1991 Dec; 5(6):531-8. PubMed ID: 1958380
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of emodin on bleomycin-induced pulmonary fibrosis in mice.
Chen XH; Sun RS; Hu JM; Mo ZY; Yang ZF; Jin GY; Guan WD; Zhong NS
Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):146-53. PubMed ID: 18785980
[TBL] [Abstract][Full Text] [Related]
17. Human amnion epithelial cells prevent bleomycin-induced lung injury and preserve lung function.
Murphy S; Lim R; Dickinson H; Acharya R; Rosli S; Jenkin G; Wallace E
Cell Transplant; 2011; 20(6):909-23. PubMed ID: 21092408
[TBL] [Abstract][Full Text] [Related]
18. Imbalance in the pro-hepatocyte growth factor activation system in bleomycin-induced lung fibrosis in mice.
Phin S; Marchand-Adam S; Fabre A; Marchal-Somme J; Bantsimba-Malanda C; Kataoka H; Soler P; Crestani B
Am J Respir Cell Mol Biol; 2010 Mar; 42(3):286-93. PubMed ID: 19448157
[TBL] [Abstract][Full Text] [Related]
19. The role of high mobility group box1 in pulmonary fibrosis.
Hamada N; Maeyama T; Kawaguchi T; Yoshimi M; Fukumoto J; Yamada M; Yamada S; Kuwano K; Nakanishi Y
Am J Respir Cell Mol Biol; 2008 Oct; 39(4):440-7. PubMed ID: 18441281
[TBL] [Abstract][Full Text] [Related]
20. The extracellular matrix glycoprotein Tenascin-C is expressed by oligodendrocyte precursor cells and required for the regulation of maturation rate, survival and responsiveness to platelet-derived growth factor.
Garwood J; Garcion E; Dobbertin A; Heck N; Calco V; ffrench-Constant C; Faissner A
Eur J Neurosci; 2004 Nov; 20(10):2524-40. PubMed ID: 15548197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
